Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

Fact checked by Jennifer Klump Although respiratory syncytial virus (RSV) is often associated with children, adults can also ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

The primary cohort (to assess the RSV outcome) was comprised of 18,767 children with SARS-CoV-2 infection, 6,697 with ...

NHS specialists have called on those eligible for a respiratory syncytial virus (RSV) jab to get vaccinated following a spike ...

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

Newborn babies whose mother received the RSV vaccination during pregnancy were about 80% less likely to be admitted to ...

Among adults 65 and older, about 177,000 are hospitalized with RSV and 14,000 die annually. Worldwide, RSV kills about 100,000 children a year, mostly in poor countries. Why is there no vaccine?

With COVID-19 hospitalizations rising and flu and RSV on the horizon, experts say it’s time to boost up your immunity ahead of the fall and winter season. Here are answers to some frequently ...

RSV infections of the lungs and airways send up to 160,000 older adults to the hospital each year, at an annual cost of more than $1.3 billion, according to the Michigan Medicine report.